Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis
Main Authors: | , , , , , , , , , , |
---|---|
פורמט: | Conference item |
שפה: | English |
יצא לאור: |
Journal of Rheumatology
2022
|